Goncalves Joanainsider trades
In SEC Form 4 filings, Goncalves Joana is listed as Chief Medical Officer of Oruka Therapeutics, Inc. (ORKA). In the last 90 days, Goncalves Joana sold $1.26M of Oruka Therapeutics, Inc. (ORKA) on the open market and bought none. All 10 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| ORKAOruka Therapeutics, Inc. | Chief Medical Officer | 18 | Oct 15 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-15
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| ORKAOruka Therapeutics, Inc. | Oct 15 | Oct 15 | M | 3,500 | $6.84 | $23,940 | 35,271 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 15 | Oct 15 | M | 3,500 | $7.80 | $27,300 | 38,771 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 15 | Oct 15 | S | 2,853 | $73.89 | Sale −$210,806 | 35,918 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 15 | Oct 15 | S | 1,847 | $74.69 | Sale −$137,957 | 34,071 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 15 | Oct 15 | S | 1,400 | $75.48 | Sale −$105,677 | 32,671 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 15 | Oct 15 | S | 700 | $76.67 | Sale −$53,666 | 31,971 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 15 | Oct 15 | S | 200 | $77.71 | Sale −$15,542 | 31,771 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 15 | Oct 15 | M · derivative | 3,500 | $6.84 | $23,940 | 190,063 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Oct 15 | Oct 15 | M · derivative | 3,500 | $7.80 | $27,300 | 161,492 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 15 | Sep 15 | M | 3,500 | $6.84 | $23,940 | 36,218 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 15 | Sep 15 | M | 3,500 | $7.80 | $27,300 | 39,718 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 15 | Sep 15 | S | 2,384 | $91.10 | Sale −$217,173 | 37,334 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 15 | Sep 15 | S | 3,150 | $92.03 | Sale −$289,890 | 34,184 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 15 | Sep 15 | S | 1,366 | $92.99 | Sale −$127,023 | 32,818 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 15 | Sep 15 | S | 100 | $94.22 | Sale −$9,422 | 32,718 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 15 | Sep 15 | S | 947 | $95.71 | Sale −$90,637 | 31,771 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 15 | Sep 15 | M · derivative | 3,500 | $6.84 | $23,940 | 193,563 | Yes | Form 4 |
| ORKAOruka Therapeutics, Inc. | Sep 15 | Sep 15 | M · derivative | 3,500 | $7.80 | $27,300 | 164,992 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.